| London Stock Exchange: AGL
Similar to: LED Medical Diagnostics, Inc.
ANGLE Plc operates as a holding company, the company through its subsidiaries, Parsortix, Inc., Novocellus Ltd. and Geomerics Ltd. provides products in cancer diagnostics and foetal health and computer graphics technology platform services. The company operates through three segments: Controlled investments, Non-controlled investments and Management services. The Controlled investments include parsortix, novocellus and neuroTargets. The Non-controlled investments comprises geomerics and the earn-out in relation to the sale of acolyte biomedica. The Management services include provision of Management services to clients including research organisations, corporate and governmental organisations on a fee-for-service basis. ANGLE was founded by Andrew Newland in April 1994 and is headquartered in Guildford, the United Kingdom.